Sheffield University spinout Defenition is set to receive up to £415,000 ($525,000) from commericalisation firm IP Group to help it develop a new class of antibiotics. The company was founded in 2016 and will use part of the funding to support research in collaboration with the Department of Infection, Immunity and Cardiovascular Disease.
Stanford University’s StartX fund has contributed to a $2m seed round for Lexigram, a US-based developer of on-demand natural language processing technology aimed at the healthcare sector. The round was led by Storm Ventures and also included RTA Ventures. Lexigram is a spinout of Stanford’s Center for Biomedical Informatics Research.
GV, the early-stage investment arm of conglomerate Alphabet, has helped put $8m in series B funding in US-based cell engineering technology producer SQZ Biotech. The round also included Quark Venture and added to a $16m first close co-led by NanoDimension and Polaris Partners this past September. The company’s technology is based on research conducted at Massachusetts Institute of Technology.
Cambridge University and Jiangnan University are set to exploit research conducted at the Cambridge Graphene Centre that enables a wearable motion sensor based on conductive cotton, according to Business Weekly. The work is being commercialised by Cambridge’s tech transfer office Cambridge Enterprise, though further details about the spinout have not yet emerged.
– This article has been updated to reflect that SQZ Biotech in fact raised $8m in its series B extension and not $4m as previously stated.
